Pfizer Inc. (FRA:PFE)
21.97
-0.23 (-1.04%)
Aug 22, 2025, 7:42 PM CET
Pfizer Revenue
Pfizer had revenue of $14.65B USD in the quarter ending June 29, 2025, with 10.31% growth. This brings the company's revenue in the last twelve months to $63.83B, up 13.53% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$63.83B
Revenue Growth
+13.53%
P/S Ratio
2.30
Revenue / Employee
$788.06K
Employees
81,000
Market Cap
125.47B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
Pfizer News
- 1 day ago - Price Over Earnings Overview: Pfizer - Benzinga
- 2 days ago - This Is What Whales Are Betting On Pfizer - Benzinga
- 2 days ago - Low Volatility Calls For This Breakout Trade On Pfizer Stock - Investor's Business Daily
- 2 days ago - Pfizer: Shares Are Cheap, But They Could Get Even Cheaper Next Year - Seeking Alpha
- 3 days ago - Pfizer: Stagnation Is An Investment Opportunity - Seeking Alpha
- 4 days ago - Pfizer sued by Enanta in EU over patent infringement related to COVID pill - Seeking Alpha
- 4 days ago - Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union - Wallstreet:Online
- 5 days ago - Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True? - The Motley Fool